In this latter study, the enhanced uptake of the radiolabeled minigastrin was specific to CCKBR-expressing tumors, whereas the uptake in the gastrointestinal tract, which expresses endogenous CCKBR, was unchanged, presumably due to the fact that, in contrast to healthy tissue, cancers have high activity of mTORC1. Here, CCKBR is linked to cancer.